Acceleron is dedicated to the discovery, development, and commercialization of life-changing medicines. Our approach to drug discovery is driven by deep scientific expertise and harnessing the power of the TGF-beta protein superfamily to deliver effective treatments to patients with limited or no therapeutic options. Together with our global collaboration partner, Celgene, we are pioneering the development of innovative therapies in hematology.